Tuberculosis in Africa

According to the article Africa is facing the worst tuberculosis epidemic which is driven by the human immunodeficiency virus (HIV) and its weak health care system, inadequate laboratories and helpful conditions to transmitting the infection it is constantly becoming worse.  Even though Africa is 11% of the world’s population it carries 29% of the global burden of tuberculosis and 34% related deaths. They say that the growth of tuberculosis is due to numerous of things mainly including HIV.  HIV is Africa’s leading cause of death but tuberculosis is the most common coexisting condition in people who die from AIDS. They have the President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria but unfortunately most of the money is focused more on HIV. Unfortunately the cycle of this disease is amplified by the interaction between patients with active tuberculosis and the HIV infection in clinics, hospitals and the community. Treatments and the use of drugs don’t even help; most patients still die due to tuberculosis. This article suggest that rapid detection and drugs with shorter cure times and improved outcomes is just what Africa needs and I would have to agree with them. Something needs to be done to help. If they even came up with a drug to prevent others and future generations from getting tuberculosis that would be a tremendous help with tuberculosis instead of letting the people suffer and die. Even the world’s widely used vaccine, Guerin, proves that it is effective in adults to help with tuberculosis. More than half a million people die from tuberculosis in Africa from tuberculosis and a cure needs to come quickly or more people will die. Africa needs a lot of help in terms of research, healthy systems, laboratories, human resource and public health services otherwise more people will suffer.

 

“Tuberculosis in Africa – Combating an HIV-Driven Crisis — NEJM.” New England Journal of Medicine. N.p., n.d. Web. 08 Aug. 2014.

http://www.nejm.org/doi/full/10.1056/NEJMp0800809

This Post Has 0 Comments

Leave a Reply